Rockwell Medical Technologies (RMTI) Misses Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Rockwell Medical Technologies (RMTI) Misses Q1 EPS by 2c

Rockwell Medical Reports First Quarter Results

May 10, 2016 4:01 PM EDT

WIXOM, Mich., May 10, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the first quarter of 2016.

Q1 2016 Financial Highlights

Sales were $13.6 million, compared to $13.9 million in Q1 2015, or 1.9% less than Q1 2015.Dialysis concentrate sales increased $0.2 million while contract manufacturing sales decreased... More